Replies to post #2666 on Entremed (ENMD)

[phronimos]

ENMD's stake in endostatin

Ironic that we are hearing news of endostatin, when the focus has been so much on Panzem. Obviously, ENMD no longer is involved in the development of endostatin and angiostatin. But in case anyone has forgotten -- Entremed will receive "20% of all future proceeds (e.g. upfront, milestone and royalty payments) resulting from any subsequent CMCC [Children's Medical Center Corp.] license [for endostatin or angiostatin] outside of Asia."

http://investor.entremed.com/ireye/ir_site.zhtml?ticker=ENMD&script=410&layout=-6&item_i...

[cycle dude]

Endostar, Medgenn's name for YH-16, they presented at 2005 ASCO, they treated 486 patients...do a google "yh-16 lung cancer"